Cindy Jacobson

1.9k total citations
15 papers, 271 citations indexed

About

Cindy Jacobson is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Cindy Jacobson has authored 15 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Microbiology. Recurrent topics in Cindy Jacobson's work include HIV/AIDS Research and Interventions (14 papers), HIV, Drug Use, Sexual Risk (7 papers) and Reproductive tract infections research (7 papers). Cindy Jacobson is often cited by papers focused on HIV/AIDS Research and Interventions (14 papers), HIV, Drug Use, Sexual Risk (7 papers) and Reproductive tract infections research (7 papers). Cindy Jacobson collaborates with scholars based in United States, South Africa and Malawi. Cindy Jacobson's co-authors include Ian McGowan, Beatrice A. Chen, Barbra A. Richardson, Irma Febo, Kailazarid Gomez, Edward Livant, Marla Husnik, Clare F. Price, Karen Bruder and Charlene S. Dezzutti and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Cindy Jacobson

14 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cindy Jacobson United States 8 173 105 90 82 52 15 271
Edward Livant United States 9 149 0.9× 93 0.9× 93 1.0× 53 0.6× 43 0.8× 15 275
Justin T. Clark United States 8 190 1.1× 91 0.9× 81 0.9× 177 2.2× 75 1.4× 10 401
Kavita M. Gupta United States 6 125 0.7× 69 0.7× 48 0.5× 137 1.7× 36 0.7× 11 341
Thanyanan Chaowanachan Thailand 12 206 1.2× 171 1.6× 133 1.5× 79 1.0× 56 1.1× 16 442
Ryan J. Morrow United Kingdom 10 184 1.1× 136 1.3× 86 1.0× 222 2.7× 57 1.1× 12 522
Kailazarid Gomez United States 10 351 2.0× 168 1.6× 182 2.0× 136 1.7× 128 2.5× 12 510
Irina Butkyavichene United States 10 211 1.2× 113 1.1× 109 1.2× 194 2.4× 56 1.1× 10 376
Chuong Dinh United States 12 284 1.6× 184 1.8× 110 1.2× 118 1.4× 34 0.7× 32 376
Jens Van Roey Belgium 9 339 2.0× 226 2.2× 127 1.4× 257 3.1× 58 1.1× 12 502
Flora Yang United States 7 180 1.0× 118 1.1× 77 0.9× 53 0.6× 24 0.5× 9 324

Countries citing papers authored by Cindy Jacobson

Since Specialization
Citations

This map shows the geographic impact of Cindy Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Jacobson more than expected).

Fields of papers citing papers by Cindy Jacobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Jacobson. The network helps show where Cindy Jacobson may publish in the future.

Co-authorship network of co-authors of Cindy Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Jacobson. A scholar is included among the top collaborators of Cindy Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Jacobson. Cindy Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Liu, Albert, Holly Gundacker, Barbra A. Richardson, et al.. (2024). Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States. Journal of the International AIDS Society. 27(3). e26223–e26223. 1 indexed citations
3.
Bauermeister, José A., Albert Liu, Suwat Chariyalertsak, et al.. (2024). A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN‐035. Journal of the International AIDS Society. 27(3). e26219–e26219. 1 indexed citations
4.
5.
Ho, Ken, Daniel Szydlo, Sharon A. Riddler, et al.. (2022). MTN-033: a Phase 1 Study Comparing Applicator versus “as Lubricant” Delivery of Rectal Dapivirine Gel. Antimicrobial Agents and Chemotherapy. 66(11). e0081622–e0081622. 2 indexed citations
6.
Liu, Albert, Holly Gundacker, Blažej Neradilek, et al.. (2021). Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. Journal of the International AIDS Society. 24(6). e25747–e25747. 17 indexed citations
7.
McGowan, Ian, Craig W. Hendrix, Peter A. Anton, et al.. (2021). A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study). AIDS Research and Human Retroviruses. 38(4). 269–278. 7 indexed citations
8.
Bauermeister, José A., Sherri Johnson, Jonathan Lucas, et al.. (2021). Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study). AIDS Education and Prevention. 33(5). 361–376. 5 indexed citations
9.
Bauermeister, José A., Jesse Golinkoff, Alex Carballo‐Diéguez, et al.. (2019). A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027. AIDS and Behavior. 24(2). 607–616. 9 indexed citations
10.
Liu, Albert, Jingyang Zhang, Peter L. Anderson, et al.. (2018). Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048. Clinical Infectious Diseases. 68(7). 1129–1135. 15 indexed citations
11.
Hoesley, Craig, Beatrice A. Chen, Peter L. Anderson, et al.. (2018). Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings. Clinical Infectious Diseases. 68(7). 1136–1143. 24 indexed citations
12.
Chen, Beatrice A., Jingyang Zhang, Holly Gundacker, et al.. (2018). Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women. Clinical Infectious Diseases. 68(7). 1144–1151. 22 indexed citations
13.
McGowan, Ian, Ross Cranston, Kenneth H. Mayer, et al.. (2016). Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women. PLoS ONE. 11(6). e0158310–e0158310. 14 indexed citations
14.
McGowan, Ian, Ross Cranston, Cindy Jacobson, et al.. (2015). A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study). PLoS ONE. 10(5). e0125363–e0125363. 49 indexed citations
15.
McGowan, Ian, Kailazarid Gomez, Karen Bruder, et al.. (2011). Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 25(8). 1057–1064. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Livant Breakdown of academic impact, for papers by Justin T. Clark Breakdown of academic impact, for papers by Kavita M. Gupta Breakdown of academic impact, for papers by Thanyanan Chaowanachan Breakdown of academic impact, for papers by Ryan J. Morrow Breakdown of academic impact, for papers by Kailazarid Gomez Breakdown of academic impact, for papers by Irina Butkyavichene Breakdown of academic impact, for papers by Chuong Dinh Breakdown of academic impact, for papers by Jens Van Roey Breakdown of academic impact, for papers by Flora Yang
Rankless by CCL
2026